Nefrolojik Hastalıkların Nörolojik Bulguları
Özet
Böbrek hastalıkları, üremik ensefalopati, akut hipertansiyon, hemolitik üremik sendrom ve nakil sonrası komplikasyonlar gibi çeşitli nörolojik sorunları beraberinde getirebilir. Tedavi edilmeyen böbrek yetmezliği, merkezi sinir sistemi üzerinde ensefalopati ve nöbetlerden periferik nöropatilere kadar uzanan ciddi tablolara yol açabilir. Genetik faktörler de böbrek ve sinir sistemini eş zamanlı etkileyerek farklı klinik tabloların gelişmesine neden olabilmektedir. Erken teşhis ve uygun renal replasman veya ilaç tedavileri, bu nörolojik komplikasyonların yönetimi ve önlenmesi açısından kritik öneme sahiptir.
Kidney diseases can be accompanied by various neurological issues, including uremic encephalopathy, acute hypertension, hemolytic uremic syndrome, and post-transplant complications. Untreated renal failure can lead to severe conditions affecting the central nervous system, ranging from encephalopathy and seizures to peripheral neuropathies. Genetic factors may also simultaneously affect both the kidneys and the nervous system, leading to distinct clinical presentations. Early diagnosis and appropriate renal replacement or pharmacological therapies are critical for managing and preventing these neurological complications.
Referanslar
Palmer CA. Neurologic manifestations of renal disease. Neurol Clin. 2002;20(1):23-v.
Hocker SE. Renal Disease and Neurology. Continuum (Minneap Minn). 2017;23(3, Neurology of Systemic Disease):722-743.
Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011;31(2):139-143.
Olano CG, Akram SM, Bhatt H. Uremic Encephalopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 31, 2021.
Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Expert Rev Clin Pharmacol. 2019;12(1):61-90.
Yoganathan S, Bagga A, Gulati S, et al. Prevalence and predictors of peripheral neuropathy in nondiabetic children with chronic kidney disease. Muscle Nerve. 2018;57(5):792-798.
Seeman T, Hamdani G, Mitsnefes M. Hypertensive crisis in children and adolescents. Pediatr Nephrol. 2019;34(12):2523-2537.
Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887-1920.
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents [published correction appears in Pediatrics. 2017 Nov 30;:] [published correction appears in Pediatrics. 2018 Sep;142(3):]. Pediatrics. 2017;140(3):e20171904.
Wu HP, Yang WC, Wu YK, Zhao LL, Chen CY, Fu YC. Clinical significance of blood pressure ratios in hypertensive crisis in children. Arch Dis Child. 2012;97(3):200-205.
Lee GH, Lee IR, Park SJ, Kim JH, Oh JY, Shin JI. Hypertensive crisis in children: an experience in a single tertiary care center in Korea. Clin Hypertens. 2016;22:10.
Jörg R, Milani GP, Simonetti GD, Bianchetti MG, Simonetti BG. Peripheral facial nerve palsy in severe systemic hypertension: a systematic review. Am J Hypertens. 2013;26(3):351-356.
Ahn CH, Han SA, Kong YH, Kim SJ. Clinical characteristics of hypertensive encephalopathy in pediatric patients. Korean J Pediatr. 2017;60(8):266-271.
Kovalski Y, Cleper R, Krause I, Dekel B, Belenky A, Davidovits M. Hyponatremic hypertensive syndrome in pediatric patients: is it really so rare?. Pediatr Nephrol. 2012;27(6):1037-1040.
Mukherjee D, Sinha R, Akhtar MS, Saha AS. Hyponatremic hypertensive syndrome - a retrospective cohort study. World J Nephrol.
Ishikura K, Hamasaki Y, Sakai T, Hataya H, Mak RH, Honda M. Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol. 2012;27(3):375-384.
Gavrilovici C, Miron I, Voroneanu L, Bădărau S, Stârcea M. Posterior reversible encephalopathy syndrome in children with kidney disease. Int Urol Nephrol. 2017;49(10):1793-1800.
Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol. 2001;16(7):537-542
Stott VL, Hurrell MA, Anderson TJ. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J. 2005;35(2):83-90.
Lamy C, Oppenheim C, Méder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging. 2004;14(2):89-96.
Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69(4):467-472.
Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol. 2009;31(7):505-508.
Epker JL, van Biezen P, van Daele PL, van Gelder T, Vossen A, van Saase JL. Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states. Eur J Intern Med. 2009;20(3):261-267.
Kumar D. Emerging viruses in transplantation. Curr Opin Infect Dis. 2010;23(4):374-378.
Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33(2):230-236.
Tavasoli A, Zafaranloo N, Hoseini R, Otukesh H, Hooman N, Panahi P. Chronic Neurological Complications in Hemolytic Uremic Syndrome in Children. Iran J Kidney Dis. 2019;13(1):32-35.
Fidan K, Göknar N, Gülhan B, et al. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2018;33(8):1395-1403.
Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019;34(8):1337-1348.
Gulleroglu K, Fidan K, Hançer VS, Bayrakci U, Baskin E, Soylemezoglu O. Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol. 2013;28(5):827-830.
Koehl B, Boyer O, Biebuyck-Gougé N, et al. Neurological involvement in a child with atypical hemolytic uremic syndrome. Pediatr Nephrol. 2010;25(12):2539-2542.
Diamante Chiodini B, Davin JC, Corazza F, et al. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Pediatrics. 2014;133(6):e1764-e1768.
Ghosh PS, Kwon C, Klein M, Corder J, Ghosh D. Neurologic complications following pediatric renal transplantation. J Child Neurol. 2014;29(6):793-798.
Bohlin AB, Berg U, Englund M, et al. Central nervous system complications in children treated with ciclosporin after renal transplantation. Child Nephrol Urol. 1990;10(4):225-230.
Mour G, Wu C. Neurologic Complications After Kidney Transplantation. Semin Nephrol. 2015;35(4):323-334.
McEnery PT, Nathan J, Bates SR, Daniels SR. Convulsions in children undergoing renal transplantation. J Pediatr. 1989;115(4):532-536.
Awan AQ, Lewis MA, Postlethwaite RJ, Webb NJ. Seizures following renal transplantation in childhood. Pediatr Nephrol. 1999;13(4):275-277.
Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69(4):467-472.
Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233-1243.
